Johnson & Johnson (NYSE:JNJ)
| 158.26 Delayed Data As of Feb 26 |  -4.50 / -2.76%Today’s Change | 109.16 Today|||52-Week Range 173.65 | +0.56% Year-to-Date |
JNJ Regular Dividend: JNJ began trading ex-dividend on 02/22/21. A $1.01 dividend will be paid to shareholders of record as of 02/23/21.
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 162.76 |
| Today’s open | 162.13 |
| Day’s range | 158.00 - 162.16 |
| Volume | 14,417,547 |
| Average volume (3 months) | 7,829,386 |
| Market cap | $429.1B |
Data as of 5:26pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +18.31% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +0.57% |
| P/E ratio | 28.8 |
| Price/Sales | 4.98 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.80 | -0.92% |
| LLYEli Lilly and Co | +0.89 | +0.44% |
| ABBVAbbVie | +0.40 | +0.37% |
| MRKMerck | -1.97 | -2.64% |
Data as of 4:50pm ET, 02/26/2021
Financials
| Next reporting date | April 20, 2021 |
| EPS forecast (this quarter) | $2.32 |
| Annual revenue (last year) | $82.6B |
| Annual profit (last year) | $14.7B |
| Net profit margin | 17.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
